At US$34.69, Is AtriCure, Inc. (NASDAQ:ATRC) Worth Looking At Closely?

Simply Wall StJan 15 07:05 ET

Stifel Maintains AtriCure(ATRC.US) With Buy Rating

Moomoo NewsJan 13 20:31 ET · Ratings

AtriCure's Strong Performance and Promising Outlook Justify Buy Rating Amid Competitive Pressures

TipRanksJan 13 20:09 ET · Ratings

Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsJan 13 10:31 ET · Ratings

AtriCure Announces Q4 2024 Preliminary Revenue Of $124.3M, Up 17%, And FY Revenue Of $465.3M, U.S. Revenue Up 14% To $101.6M, International Revenue Increased 28% To $22.7M; Forecasted 2024 Adjusted EBITDA Is $26M-$29M And Adjusted Loss Per Share Is...

BenzingaJan 13 08:42 ET

AtriCure | 8-K: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day

SECJan 13 08:02 ET · Announcements